These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8294198)

  • 1. Comparison of contingent negative variation between migraine interval and migraine attack before and after treatment with sumatriptan.
    Göbel H; Krapat S; Ensink FB; Soyka D
    Headache; 1993; 33(10):570-2. PubMed ID: 8294198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exteroceptive suppression of temporalis muscle activity during migraine attack and migraine interval before and after treatment with sumatriptan.
    Göbel H; Krapat S; Dworschak M; Heuss D; Ensink FB; Soyka D
    Cephalalgia; 1994 Apr; 14(2):143-8. PubMed ID: 8062353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack.
    Kropp P; Gerber WD
    Cephalalgia; 1995 Apr; 15(2):123-8; discussion 78-9. PubMed ID: 7641246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral blood flow during migraine attacks without aura and effect of sumatriptan.
    Ferrari MD; Haan J; Blokland JA; Arndt JW; Minnee P; Zwinderman AH; Pauwels EK; Saxena PR
    Arch Neurol; 1995 Feb; 52(2):135-9. PubMed ID: 7848120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
    Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interictal and postictal contingent negative variation in migraine without aura.
    Mulder EJ; Linssen WH; Passchier J; de Geus EJ
    Headache; 2001 Jan; 41(1):72-8. PubMed ID: 11168606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurophysiological reactivity before a migraine attack.
    Siniatchkin M; Averkina N; Andrasik F; Stephani U; Gerber WD
    Neurosci Lett; 2006 May; 400(1-2):121-4. PubMed ID: 16540242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study.
    Tfelt-Hansen P; Bach FW; Daugaard D; Tsiropoulos I; Riddersholm B
    J Headache Pain; 2006 Dec; 7(6):389-94. PubMed ID: 17164991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it?
    Calhoun AH; Ford S
    Postgrad Med; 2014 Mar; 126(2):86-90. PubMed ID: 24685971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
    Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
    Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contingent negative variation in childhood migraine.
    Besken E; Pothmann R; Sartory G
    Cephalalgia; 1993 Feb; 13(1):42-3. PubMed ID: 8448788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice.
    Russell MB; Holm-Thomsen OE; Rishøj Nielsen M; Cleal A; Pilgrim AJ; Olesen J
    Cephalalgia; 1994 Aug; 14(4):291-6. PubMed ID: 7954759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral sumatriptan for the long-term treatment of migraine: clinical findings.
    Rederich G; Rapoport A; Cutler N; Hazelrigg R; Jamerson B
    Neurology; 1995 Aug; 45(8 Suppl 7):S15-20. PubMed ID: 7644080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
    Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of migraine attacks using a slow cortical potential, the contingent negative variation.
    Kropp P; Gerber WD
    Neurosci Lett; 1998 Nov; 257(2):73-6. PubMed ID: 9865930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.